Categories Multiple Myeloma

Global Melphalan Market 2021– Industry Insights, Drivers, Top Trends, Global Analysis And …

Global Melphalan Market 2021– Industry Insights, Drivers, Top Trends, Global Analysis And … “A SWOT Analysis of Melphalan, Professional Survey Report Including Top Most Global Players Analysis with CAGR and Stock Market Up and Down.” The global “Melphalan market” research report offers a comprehensive analysis and forecasts of the Melphalan market at both the global and […]

Read More
Categories Parkinson's Disease

What Market Research Will Tell You

What will the results of market research tell a business?  This article highlights how information gained from market research can really help your business. What can you learn from having conducting effective market research? Know your customers – Market research will help you better understand your customers in a number of ways including demographic information […]

Read More
Categories Cancer

Randy Carver persevered through a heart attack, cancer, and a plane crash to succeed as a …

Randy Carver persevered through a heart attack, cancer, and a plane crash to succeed as a … Randy Carver. Randy Carver This story is available exclusively to Insider subscribers. Become an Insider and start reading now. Randy Carver has gone through multiple setbacks in life to prevail in the financial industry. Carver started trading silver […]

Read More
Categories Cancer

Biochimica et Biophysica Acta (BBA) – Reviews on Cancer | Vol 1875, Issue 2, In progress (April …

Biochimica et Biophysica Acta (BBA) – Reviews on Cancer | Vol 1875, Issue 2, In progress (April … select article Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy https://doi.org/10.1016/j.bbcan.2020.188500 Review articleAbstract only Clusterin as modulator of carcinogenesis: A potential avenue for targeted cancer therapy Prakash Priyadarshi Praharaj, Srimanta Patra, Debasna Pritimanjari […]

Read More
Categories Multiple Myeloma

FDA Approves Ide-Cel for Relapsed/Refractory Multiple Myeloma

FDA Approves Ide-Cel for Relapsed/Refractory Multiple Myeloma The FDA has approved idecabtagene vicleucel (ide-cel; formerly bb2121; Abecma) for the treatment of adult patients with relapsed or refractory multiple myeloma after 4 or more prior therapies, including an immunomodulatory drug (IMiD), a proteasome inhibitor (PI), and an anti-CD38 antibody.1 Ide-cel represents the first B-cell maturation antigen […]

Read More
Categories Cancer

Oncology Investors to Hear “Cancer Device Company of the Year” Immunicom Present at …

Oncology Investors to Hear “Cancer Device Company of the Year” Immunicom Present at … CEO Amir Jafri will demonstrate how his FDA Breakthrough Device’s platform-based, subtractive therapy business model optimizes standard of care and shareholder value. Immunicom, Inc., a global biotechnology company pioneering novel “subtractive” immunotherapies, today announced CEO Amir Jafri will speak at MedInvest’s […]

Read More